Arthritis Research & Therapy has launched a new thematic series dedicated to the topic Digital Rheumatology.
Deadline for submissions has been extended to 15th May 2021. Find out more here
Call for Papers: Thematic series on Digital Rheumatology
Articles
-
-
Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis
-
Toll-like receptor 2 induced senescence in intervertebral disc cells of patients with back pain can be attenuated by o-vanillin
-
Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis—the ANSWER cohort study
-
Risk of gout among Taiwanese adults with ALDH-2 rs671 polymorphism according to BMI and alcohol intake
-
Use of NSAIDs in treating patients with arthritis
-
Repression of anti-proliferative factor Tob1in osteoarthritic cartilage
-
Degeneration of the intervertebral disc
-
Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence
-
Complement and systemic lupus erythematosus
Join our 20th anniversary celebrations by browsing through the journal’s milestone achievements and our specially commissioned Editorial collection.
Editors-in-Chief
Professor Christopher Buckley, University of Birmingham and University of Oxford, UK
Professor Harris Perlman, Northwestern University, USA
Trending articles
Click here to view which articles have been shared the most in the last month.
First Author Profiles
Meet this month's featured authors!
Aims and scope
Established in 1999, Arthritis Research and Therapy is an international, open access, peer-reviewed journal, publishing original articles in the area of musculoskeletal research and therapy as well as, reviews, commentaries and reports.
A major focus of the journal is on the immunologic processes leading to inflammation, damage and repair as they relate to autoimmune rheumatic and musculoskeletal conditions, and which inform the translation of this knowledge into advances in clinical care.
Original basic, translational and clinical research is considered for publication along with results of early and late phase therapeutic trials, especially as they pertain to the underpinning science that informs clinical observations in interventional studies.
A major focus of the journal is on the immunologic processes leading to inflammation, damage and repair as they relate to autoimmune rheumatic and musculoskeletal conditions, and which inform the translation of this knowledge into advances in clinical care.
Original basic, translational and clinical research is considered for publication along with results of early and late phase therapeutic trials, especially as they pertain to the underpinning science that informs clinical observations in interventional studies.
Prognostic factors for progression of osteoarthritis of the hip: a systematic review
The hip is the third joint most commonly affected by osteoarthritis (OA) and with no therapeutic cure for hip OA, predicting which patients with hip OA are more likely to show disease progression is important for healthcare professionals.
In this systematic review, Teirlinck et al assess the existing evidence of patient, health, and diagnostic variables associated with the progression in patients with hip osteoarthritis.
Follow
Annual Journal Metrics
-
Speed
62 days to first decision for reviewed manuscripts only
47 days to first decision for all manuscripts
129 days from submission to acceptance
21 days from acceptance to publicationCitation Impact
4.103 - 2-year Impact Factor
4.686 - 5-year Impact Factor
1.297 - Source Normalized Impact per Paper (SNIP)
1.684 - SCImago Journal Rank (SJR)Usage
2,291,634 Downloads
964 Altmetric mentions
